These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24716193)

  • 1. Streamlining cutaneous melanomas in young women of the Belgian Mosan region.
    Hermanns-Lê T; Piérard S
    Biomed Res Int; 2014; 2014():320767. PubMed ID: 24716193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mosan Study Group of pigmented neoplasms.
    Piérard GE
    Dermatologica; 1988; 176(3):124-9. PubMed ID: 3378649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
    Whiteman DC; Watt P; Purdie DM; Hughes MC; Hayward NK; Green AC
    J Natl Cancer Inst; 2003 Jun; 95(11):806-12. PubMed ID: 12783935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
    Tsao H; Bevona C; Goggins W; Quinn T
    Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients.
    Egan CL; Oliveria SA; Elenitsas R; Hanson J; Halpern AC
    J Am Acad Dermatol; 1998 Dec; 39(6):923-32. PubMed ID: 9843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of nonacral melanoma patients without typical risk factors.
    Canelas MM; Bermejo JL; Landi MT; Requena C; Guillen C; Kumar R; Nagore E
    Melanoma Res; 2012 Aug; 22(4):316-9. PubMed ID: 22516967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.
    Rhodes AR
    Med Clin North Am; 1986 Jan; 70(1):3-37. PubMed ID: 3510347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy.
    Naldi L; Randi G; Di Landro A; La Vecchia C
    Arch Dermatol; 2006 Jul; 142(7):935-6. PubMed ID: 16847220
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
    Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
    JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
    Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic melanocytic nevi in histologic association with primary cutaneous melanomas.
    Maize JC
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):831-5. PubMed ID: 6373857
    [No Abstract]   [Full Text] [Related]  

  • 14. Numerous, small, darkly pigmented melanocytic nevi: the cheetah phenotype.
    Huynh PM; Glusac EJ; Alvarez-Franco M; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2003 May; 48(5):707-13. PubMed ID: 12734499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.
    Cress RD; Holly EA; Ahn DK; LeBoit PE; Sagebiel RW
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):831-6. PubMed ID: 8634653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
    Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
    Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.
    Elder DE; Goldman LI; Goldman SC; Greene MH; Clark WH
    Cancer; 1980 Oct; 46(8):1787-94. PubMed ID: 7427881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevus-associated melanomas: clinicopathologic features.
    Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
    Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.